Keyphrases
Low Molecular Weight Heparin
100%
Orally Active
100%
Heparin Conjugate
100%
Cancer-associated Thrombosis
100%
Prevention Effect
100%
Cancer Patients
60%
Tetrad
60%
Tumor
40%
Deoxycholic Acid
40%
Oral Delivery
40%
Tumor-bearing Mice
20%
Fibrinogen
20%
Orally Administered
20%
Oral Administration
20%
In Cancer
20%
ICR Mice
20%
Oligomeric
20%
Coagulation
20%
Thrombocytopenia
20%
Subcutaneous Injection
20%
Long-term Treatment
20%
Non-parenteral
20%
Daily Dose
20%
Saccharides
20%
Mode of Delivery
20%
Patients at Risk
20%
Thrombogenesis
20%
Local Heat
20%
Liver Toxicity
20%
Saline Injection
20%
Bile Acid Conjugates
20%
Fibrin Deposition
20%
Heat Application
20%
Tropism
20%
Parenteral Delivery
20%
Thrombosis Risk
20%
Anti-factor Xa
20%
Gastrointestinal Damage
20%
Anticoagulation Effect
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Heparin
100%
Low Molecular Weight Heparin
100%
Thrombosis
100%
Neoplasm
60%
Deoxycholic Acid
40%
Tetramer
40%
Institute for Cancer Research Mouse
20%
Bleeding
20%
Thrombocytopenia
20%
Fibrinogen
20%
Subcutaneous Injection
20%
Carbohydrates
20%
Hepatotoxicity
20%
Gastrointestinal Toxicity
20%
Bile Acid Conjugate
20%
Blood Clotting Factor 10a
20%